Chinese researchers develop immunotherapeutic agent for colon cancer
Time:2024-05-17 20:58:17 Source:styleViews(143)
TIANJIN, March 15 (Xinhua) -- Chinese researchers have developed a novel immunotherapeutic agent for treating colon cancer, according to a recent article in the academic journal ACS Nano. In animal experiments, the agent, upon successful entry into tumor cells, can enhance T cell effector function to kill tumor cells and suppress colon tumor growth, according to Lu Chunwan from the School of Life Sciences of Tianjin University, one of the authors of the article. The agent can enhance tumor immunogenicity and inhibit colon tumor growth, with no significant impact on normal cells, said Lu. Colon cancer, characterized by its long latency period and high mortality rate, poses a severe threat to human health. Among various therapies, immunotherapy is considered one of the most promising treatment directions, according to Lu.
(Editor:Fu Bo)
share to:
Previous:The Biden administration is planning more changes to quicken asylum processing for new migrants
Next:Pair of late 3
Kind tips:The above content and pictures are compiled from the Internet and are for reference only. I hope they will be helpful to you! If there is any infringement, please contact us to delete it.!
You may also like
- Meghan Markle re
- President Xi Jinping's Letter Presented to American Students
- Fourth Volume of 'Xi Jinping: The Governance of China' Published in Ethnic
- Chinese company signs MoU with Ethiopia to light up off
- Sen. Bob Menendez reveals his wife has breast cancer as his trial focuses on FBI raid of his home
- Domestic tourism industry set for 'full recovery' by summer
- Chinese medics provide free treatment to vulnerable community hosting UN peacekeepers in South Sudan
- Build a new world economic order with emerging forces: Italian economist
- Syria to develop renewable energy projects to resolve electricity shortage: minister